PromoCell: When cell-based research moves to a contract research organization (CRO), aligning cells, donor material, and scientific support across sites can help reduce avoidable variability.
Outsourcing cell-based research extends capacity and provides access to specialist expertise. But when an established workflow moves from an internal laboratory to a CRO, preserving the biological basis of the study becomes an important part of the transfer.
Although the research environment changes, key experimental inputs should remain as stable as possible. Maintaining the same cell source, donor material, and culture system gives internal teams and CRO partners a shared basis for comparison.
If results differ between sites, researchers need to know whether the difference reflects the effect they are studying or a change in the biological model. Keeping these factors aligned reduces uncertainty when interpreting results and leaves fewer avoidable variables to troubleshoot.
Using the same primary human cells, culture media, and donor or cell-lot material across internal and external laboratories gives all teams the same biological starting point.
This becomes especially important when working with primary human cells, where donor and lot differences can influence experimental readouts. A donor or cell lot selected during assay development may no longer be available when the study moves to a CRO, introducing a new variable at a later stage.
Planning ahead supports continuity through:
For studies with specific biological requirements, targeted donor pools and diverse HLA profiles give researchers greater flexibility when selecting suitable cell models.
Maintaining reproducibility depends on more than biological materials alone. Logistics, supply planning, and scientific communication also play an important role when research is distributed across multiple locations.
Even when cell models remain unchanged, differences in material availability, shipment timing, or technical guidance can affect how workflows are implemented across sites.
To support continuity throughout a project, PromoCell provides direct shipment to CRO locations, coordinated donor and cell-lot planning, and scientific support for both internal teams and CRO partners.
This helps keep teams aligned around the same materials and research requirements, rather than allowing separate versions of the workflow to develop at each site.
The goal is not to eliminate every source of variation in outsourced research. Rather, it is to control the variables that can be standardized and reduce uncertainty wherever possible.
CRO partnerships expand research capabilities, while early planning helps preserve experimental continuity. By aligning cell models, donor material, supply planning, and scientific support before work moves between locations, teams can establish a stronger foundation for comparable results across sites.
Because these elements can be sourced and coordinated through a single provider, teams can maintain greater continuity between internal laboratories and CRO partners throughout the life of a project.
PromoCell supports outsourced research through:
PromoCell’s primary human cells, specialized culture media, and donor-specific cell solutions are available in the Benelux through Bio-Connect. If you are outsourcing cell-based research or preparing a workflow transfer to a CRO, Bio-Connect can support you in identifying suitable PromoCell cell models, donor or cell-lot options, supply planning needs, and relevant support for your project.
Contact our technical support team for guidance on maintaining continuity across your CRO workflow, from cell model selection and donor planning to supply coordination and scientific guidance.
Primary Cells | Stem Cells | Buffers & solutions | Culture Media | HLA-typed cells
We gladly support you by keeping you updated on our latest products and developments
